PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm CEO Paul Rennie to transition to Non-Exec Chairman, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,143 Posts.
    lightbulb Created with Sketch. 576
    I certainly hope, as others have speculated, it is not due to health, that would be terrible news.

    If it isn't, then PR saw the writing on the wall. He was counselled that he needed to bring in a senior to help with the commercialisation - the recent 18 months SP action has probably accelerated his (unreasonable) timeline, but it was out of kilter of market expectations, and the likes of CSVF, for example.

    An immediate step down is rather drastic. In the end, it is what the company needs.


    Last edited by Gan_Gans: 22/11/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.